Document is current
Any future updates will be listed below
-
Authors
Kumar, Lakshmi
Wang, Erin
Mathai, David S.
Zamarripa, C. Austin
Spindle, Tory R.
Vandrey, Ryan
Garcia-Romeu, Albert
-
Funding
Funding for this research was provided by:
Johns Hopkins Center for Psychedelic and Consciousness Research by Tim Ferriss, Matt Mullenweg, Blake Mycoskie, Craig Nerenberg, and the Steven and Alexandra Cohen Foundation
- License Information
-
More Information
Article History
Received: 28 January 2026
Accepted: 15 May 2026
First Online: 29 May 2026
Declarations
:
: This study was deemed exempt by the Johns Hopkins University School of Medicine Institutional Review Board (IRB) because it involved minimal risk as no personally identifiable information was collected. All participants were informed of the voluntary nature of the study before proceeding and consented to participate. All research was performed in accordance with relevant guidelines/regulations and in accordance with the Declaration of Helsinki.
: Not applicable.
: DSM reported being the owner of Sattva Medicine outside the submitted work. TRS has served as a consultant for Canopy Health Innovations Inc. and Spaulding Clinical. RV has received compensation as a consultant or scientific advisory board member from Charlotte’s Web and Syqe Medical, Ltd. AGR is a paid scientific advisor to Otsuka Pharmaceutical Development & Commercialization Inc. and Psyence BioMed. AGR has received research funding from MicroDoz Therapy Inc., Mydecine Innovations Group Inc., Unlimited Sciences, the Council on Spiritual Practices, the Heffter Research Institute, NIH, and DoD. The remaining authors declare that they have no competing interests.
